Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2019 - 2021)

Historic Other Non-Current Liabilities for IDEAYA Biosciences (IDYA) over the last 3 years, with Q3 2021 value amounting to $6000.0.

  • IDEAYA Biosciences' Other Non-Current Liabilities fell 5000.0% to $6000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $6000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $12000.0 for FY2020, which is 6470.59% down from last year.
  • As of Q3 2021, IDEAYA Biosciences' Other Non-Current Liabilities stood at $6000.0, which was down 5000.0% from $6000.0 recorded in Q2 2021.
  • In the past 5 years, IDEAYA Biosciences' Other Non-Current Liabilities ranged from a high of $60000.0 in Q2 2019 and a low of $6000.0 during Q1 2021
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $14000.0 (2020), whereas its average is $22500.0.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 7692.31% in 2020, then plummeted by 5000.0% in 2021.
  • Over the past 3 years, IDEAYA Biosciences' Other Non-Current Liabilities (Quarter) stood at $34000.0 in 2019, then plummeted by 64.71% to $12000.0 in 2020, then tumbled by 50.0% to $6000.0 in 2021.
  • Its last three reported values are $6000.0 in Q3 2021, $6000.0 for Q2 2021, and $6000.0 during Q1 2021.